COMMUNIQUÉS West-GlobeNewswire

Meridian Bioscience, Inc. Expects to Report Second Quarter Fiscal Year 2018 Operating Results on Thursday, April 26, 2018

04/04/2018 - 16:00

CINCINNATI, April 04, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading diagnostic and life science component company, expects to release its second quarter fiscal 2018 operating results [...]

Tower One Provides Warrant Incentive Program Update

04/04/2018 - 15:27

VANCOUVER, British Columbia, April 04, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces the mechanism by which warrants can be executed [...]

Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018

04/04/2018 - 15:00

GR-MD-02 treatment in NASH cirrhosis patients without esophageal varices shows statistically significant and clinically meaningful effects NORCROSS, Ga., April 04, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. ( [...]

Green Cures & Botanical Distribution Announce a Company Update

04/04/2018 - 15:00

LOS ANGELES, CA, April 04, 2018 (GLOBE NEWSWIRE) -- Green Cures (OTC PINK: GRCU) is happy to announce the expansion of our Corporate Offices into a brand new dynamic space nestled in Woodland Hills California. Here we [...]

CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules

04/04/2018 - 14:57

LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE has a competitive [...]

CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

04/04/2018 - 14:45

Company Further Reduces Debt and Avoids Dilution to Stockholders LAS VEGAS, April 04, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has [...]

MJ Biotech, Inc Announces $428,000 in First Quarters Sales

04/04/2018 - 14:45

CHEYENNE, Wyo., April 04, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) Zen’s Tea House, sales results for March 2018 were just over $168,000; combining that with the January [...]

Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

04/04/2018 - 14:30

MINNEAPOLIS, April 04, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]

MyoKardia Announces Appointment of Taylor C. Harris as Chief Financial Officer

04/04/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Hemispherx Expands Ampligen Early Access Programme to Canada to Treat ME/CFS Patients

04/04/2018 - 14:30

Early Access Programs are Known as “Special Access Programme” in Canada ORLANDO, Fla., April 04, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, said it [...]

Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/04/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that on March 29, 2018, the Compensation Committee of the Board of Directors approved, [...]

SteroTherapeutics Receives FDA Orphan-Drug Designation

04/04/2018 - 14:00

PHILADELPHIA, April 04, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing therapies focused on metabolic diseases including non-alcoholic steatohepatitis (NASH), announced [...]

Trinitas-St. Joseph’s Behavioral Health Network Offers Innovative Alternative Treatment for Depression

04/04/2018 - 14:00

Transcranial Magnetic Stimulation (TMS) helps adult patients with depression who have not benefited from initial antidepressant medication therapies PATERSON, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- The Trinitas-St. [...]

CrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) Conference

04/04/2018 - 14:00

SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Rezolute Announces Appointment of Hoyoung Huh, M.D., Ph.D. as Vice Chairman of its Board of Directors

04/04/2018 - 14:00

LOUISVILLE, Colo., April 04, 2018 (GLOBE NEWSWIRE) -- Rezolute , Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies [...]

Cellectar Biosciences Appoints Brian M. Posner as Chief Financial Officer

04/04/2018 - 14:00

MADISON, Wis., April 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]

Keryx Biopharmaceuticals Announces Publication of Data from the Phase 3 Trial of Auryxia® (ferric citrate) for Iron Deficiency Anemia in Patients with Chronic Kidney Disease, Not on Dialysis, in the American Journal of Hematology

04/04/2018 - 14:00

BOSTON, April 04, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced the [...]

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

04/04/2018 - 14:00

DANVERS, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart recovery and support technologies, announced today that the Impella 5.5™ heart pump received CE [...]

Mustang Bio to Present at Biotech Innovations Conference

04/04/2018 - 14:00

NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]